Clinical Trials on Epilepsy, Tonic-Clonic in Japan
Total 782 results
-
UCB PharmaCompletedEpilepsy | Generalized Tonic-clonic SeizuresJapan
-
UCB Japan Co. Ltd.CompletedEpilepsy | Generalized Tonic-clonic SeizuresJapan
-
Eisai Co., Ltd.CompletedPartial Seizures (With or Without Secondary Generalized Seizures) | Primary Generalized Tonic-clonic SeizuresJapan
-
Eisai Co., Ltd.CompletedPartial Seizures (With or Without Secondary Generalized Seizures) | Primary Generalized Tonic-clonic SeizuresJapan
-
UCB Japan Co. Ltd.CompletedEpilepsy | Generalized Tonic-Clonic SeizuresChina, Japan
-
UCB BIOSCIENCES, Inc.Pharmaceutical Research AssociatesCompletedEpilepsyUnited States, Australia, Belgium, Brazil, Bulgaria, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Taiwan
-
UCB BIOSCIENCES, Inc.CompletedEpilepsyUnited States, Australia, Brazil, Bulgaria, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Taiwan
-
Eisai Inc.CompletedPartial-Onset or Primary Generalized Tonic-Clonic SeizuresCanada, France, Italy, Korea, Republic of, Spain, United States, Belgium, Czechia, Hungary, Japan, Latvia, Poland
-
Zogenix, Inc.RecruitingGeneralized Tonic Clonic Seizure | CDKL5 Deficiency Disorder | Epileptic Spasm | Refractory SeizuresUnited States, Japan, Germany, Netherlands, Portugal, Spain, Belgium, United Kingdom, Austria, Georgia, Israel, Ireland
-
GlaxoSmithKlineWithdrawn
-
NobelpharmaCompleted
-
GlaxoSmithKlineCompletedEpilepsyKorea, Republic of, Japan
-
GlaxoSmithKlineCompleted
-
Duke UniversityChristian Doppler University HospitalEnrolling by invitationEpilepsy IntractableUnited States, Spain, Australia, Austria, Canada, Czechia, Denmark, France, Germany, Japan, Romania, Switzerland
-
UCB Japan Co. Ltd.ParexelCompletedEpilepsy | Partial-onset SeizuresJapan
-
Nihon Pharmaceutical Co., LtdCompletedStevens-Johnson Syndrome | Toxic Epidermal NecrolysisJapan
-
Eisai Co., Ltd.Completed
-
GlaxoSmithKlineCompleted
-
Eisai Co., Ltd.CompletedLennox-Gastaut SyndromeJapan
-
UCB Japan Co. Ltd.CompletedEpilepsy | Partial-onset SeizuresJapan
-
UCB Japan Co. Ltd.CompletedEpilepsy | Partial Onset SeizuresJapan
-
Showa Inan General HospitalCompleted
-
Eisai Co., Ltd.Completed
-
Translational Research Center for Medical Innovation...Tokyo Medical and Dental UniversityCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
UCB Biopharma S.P.R.L.CompletedEpilepsy | Partial Seizures With or Without Secondary GeneralizationJapan
-
UCB Biopharma SRLTerminatedDrug-Resistant Epilepsy | Focal-Onset SeizuresUnited States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerlan... and more
-
UCB Biopharma SRLTerminatedDrug-Resistant Epilepsy | Focal-Onset SeizuresUnited States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Lithuania, Mexico, Poland, Romania, Serbia, Slovakia, Spain, Turk... and more
-
Translational Research Center for Medical Innovation...Completed
-
UCB Biopharma S.P.R.L.CompletedFocal-Onset Seizures | Drug-resistant EpilepsyUnited States, Australia, Belgium, Bulgaria, Canada, Czechia, France, Germany, Hungary, Italy, Japan, Lithuania, Mexico, Poland, Portugal, Slovakia, Spain, Turkey, United Kingdom
-
Showa Inan General HospitalRecruiting
-
Kanto CML Study GroupUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Myelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Tohoku UniversityUnknown
-
LivaNovaActive, not recruitingEpilepsy | Seizures | Drug Resistant EpilepsyAustralia, Italy, United States, Israel, United Kingdom, Canada, Brazil, Japan, Belgium, India, Austria, China, Netherlands, Poland, Portugal, Saudi Arabia
-
Novo Nordisk A/SSponsor: Corvidia Therapeutics Inc, a subsidiary of Novo Nordisk A/SCompletedInflammation | Chronic Kidney Disease | Cardiovascular RiskJapan
-
NovartisCompletedChronic Hepatitis CJapan
-
UCB Japan Co. Ltd.CompletedEpilepsy | Partial SeizuresJapan
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Yokohama City University Medical CenterCompletedDiabetes Mellitus | Renal Failure | Essential Hypertension | Chronic NephropathyJapan
-
Institute for Health Outcomes and Process Evaluation...CompletedKidney Failure, ChronicJapan
-
University of ShizuokaCompletedHemodialysis | Chronic Renal FailureJapan
-
University of ShizuokaHamamatsu University; Maruyama Memorial General HospitalCompletedAtherosclerosis | Hemodialysis | Chronic Renal FailureJapan
-
UCB Biopharma SRLActive, not recruitingEpilepsyUnited States, Hungary, Italy, Japan, Mexico, Poland, Spain
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Iwata City HospitalHamamatsu University; University of ShizuokaCompletedChronic Renal FailureJapan
-
Astellas Pharma IncCompletedPatients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy | Pharmacodynamics of ASP7991 | Pharmacokinetics of ASP7991Japan
-
University of HyogoCompletedChronic Kidney Disease on HemodialysisJapan
-
Kanto CML Study GroupUnknownMyelogenous Leukemia, Chronic, Chronic PhaseJapan